nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Fluorouracil—urinary bladder cancer	0.264	0.471	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—urinary bladder cancer	0.146	0.26	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—urinary bladder cancer	0.089	0.159	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—urinary bladder cancer	0.062	0.11	CbGbCtD
Ganciclovir—Jaundice—Doxorubicin—urinary bladder cancer	0.000183	0.000418	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—urinary bladder cancer	0.000183	0.000418	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—urinary bladder cancer	0.000183	0.000417	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—urinary bladder cancer	0.000183	0.000416	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—urinary bladder cancer	0.000183	0.000416	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000183	0.000416	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000183	0.000416	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—urinary bladder cancer	0.000182	0.000416	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—urinary bladder cancer	0.000182	0.000416	CcSEcCtD
Ganciclovir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000182	0.000415	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—urinary bladder cancer	0.000182	0.000414	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000181	0.000414	CcSEcCtD
Ganciclovir—Asthenia—Cisplatin—urinary bladder cancer	0.000181	0.000413	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—urinary bladder cancer	0.000181	0.000412	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—urinary bladder cancer	0.00018	0.000411	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00018	0.00041	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00018	0.000409	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—urinary bladder cancer	0.000179	0.000408	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000179	0.000408	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000179	0.000407	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000178	0.000405	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—urinary bladder cancer	0.000177	0.000403	CcSEcCtD
Ganciclovir—Dizziness—Fluorouracil—urinary bladder cancer	0.000176	0.000401	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—urinary bladder cancer	0.000176	0.0004	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000176	0.0004	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000175	0.0004	CcSEcCtD
Ganciclovir—Chills—Methotrexate—urinary bladder cancer	0.000175	0.000398	CcSEcCtD
Ganciclovir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000173	0.000393	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000172	0.000393	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—urinary bladder cancer	0.000172	0.000392	CcSEcCtD
Ganciclovir—Vomiting—Gemcitabine—urinary bladder cancer	0.000172	0.000392	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—urinary bladder cancer	0.000171	0.000389	CcSEcCtD
Ganciclovir—Rash—Gemcitabine—urinary bladder cancer	0.000171	0.000389	CcSEcCtD
Ganciclovir—Dermatitis—Gemcitabine—urinary bladder cancer	0.00017	0.000389	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—urinary bladder cancer	0.00017	0.000388	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—urinary bladder cancer	0.00017	0.000387	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—urinary bladder cancer	0.00017	0.000387	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00017	0.000386	CcSEcCtD
Ganciclovir—Headache—Gemcitabine—urinary bladder cancer	0.00017	0.000386	CcSEcCtD
Ganciclovir—Vomiting—Fluorouracil—urinary bladder cancer	0.000169	0.000386	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—urinary bladder cancer	0.000169	0.000386	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000169	0.000385	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000169	0.000385	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000168	0.000383	CcSEcCtD
Ganciclovir—Rash—Fluorouracil—urinary bladder cancer	0.000168	0.000382	CcSEcCtD
Ganciclovir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000168	0.000382	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000167	0.000382	CcSEcCtD
Ganciclovir—Headache—Fluorouracil—urinary bladder cancer	0.000167	0.00038	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000167	0.00038	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000166	0.000379	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—urinary bladder cancer	0.000166	0.000379	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—urinary bladder cancer	0.000166	0.000378	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000166	0.000378	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—urinary bladder cancer	0.000165	0.000377	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000377	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000164	0.000375	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—urinary bladder cancer	0.000164	0.000374	CcSEcCtD
Ganciclovir—Chills—Epirubicin—urinary bladder cancer	0.000164	0.000373	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—urinary bladder cancer	0.000164	0.000373	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—urinary bladder cancer	0.000163	0.000371	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—urinary bladder cancer	0.000163	0.000371	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—urinary bladder cancer	0.000161	0.000367	CcSEcCtD
Ganciclovir—Nausea—Gemcitabine—urinary bladder cancer	0.000161	0.000366	CcSEcCtD
Ganciclovir—Vomiting—Cisplatin—urinary bladder cancer	0.00016	0.000366	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—urinary bladder cancer	0.00016	0.000364	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—urinary bladder cancer	0.00016	0.000364	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00016	0.000364	CcSEcCtD
Ganciclovir—Rash—Cisplatin—urinary bladder cancer	0.000159	0.000363	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—urinary bladder cancer	0.000159	0.000362	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—urinary bladder cancer	0.000159	0.000362	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—urinary bladder cancer	0.000158	0.00036	CcSEcCtD
Ganciclovir—Nausea—Fluorouracil—urinary bladder cancer	0.000158	0.00036	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000157	0.000359	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—urinary bladder cancer	0.000157	0.000359	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—urinary bladder cancer	0.000157	0.000357	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—urinary bladder cancer	0.000156	0.000356	CcSEcCtD
Ganciclovir—Tension—Epirubicin—urinary bladder cancer	0.000156	0.000355	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—urinary bladder cancer	0.000155	0.000354	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—urinary bladder cancer	0.000154	0.000351	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—urinary bladder cancer	0.000154	0.00035	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—urinary bladder cancer	0.000153	0.000349	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—urinary bladder cancer	0.000153	0.000349	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—urinary bladder cancer	0.000153	0.000348	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—urinary bladder cancer	0.000153	0.000348	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—urinary bladder cancer	0.000152	0.000347	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000152	0.000347	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—urinary bladder cancer	0.000152	0.000346	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—urinary bladder cancer	0.000151	0.000345	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000151	0.000344	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—urinary bladder cancer	0.00015	0.000342	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—urinary bladder cancer	0.00015	0.000341	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—urinary bladder cancer	0.000149	0.00034	CcSEcCtD
Ganciclovir—Cough—Methotrexate—urinary bladder cancer	0.000148	0.000337	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000148	0.000337	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000147	0.000336	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—urinary bladder cancer	0.000147	0.000335	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—urinary bladder cancer	0.000147	0.000335	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000147	0.000335	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—urinary bladder cancer	0.000147	0.000334	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—urinary bladder cancer	0.000146	0.000332	CcSEcCtD
Ganciclovir—Rash—Etoposide—urinary bladder cancer	0.000146	0.000332	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—urinary bladder cancer	0.000146	0.000332	CcSEcCtD
Ganciclovir—Headache—Etoposide—urinary bladder cancer	0.000145	0.00033	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—urinary bladder cancer	0.000145	0.00033	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—urinary bladder cancer	0.000144	0.000329	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—urinary bladder cancer	0.000144	0.000329	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—urinary bladder cancer	0.000144	0.000329	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—urinary bladder cancer	0.000144	0.000328	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000144	0.000328	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000143	0.000327	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—urinary bladder cancer	0.000143	0.000326	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—urinary bladder cancer	0.000143	0.000325	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—urinary bladder cancer	0.000143	0.000325	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—urinary bladder cancer	0.000143	0.000325	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—urinary bladder cancer	0.000142	0.000324	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—urinary bladder cancer	0.000142	0.000324	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000141	0.000322	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—urinary bladder cancer	0.00014	0.000318	CcSEcCtD
Ganciclovir—Cough—Epirubicin—urinary bladder cancer	0.000139	0.000316	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000138	0.000316	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—urinary bladder cancer	0.000138	0.000315	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—urinary bladder cancer	0.000138	0.000313	CcSEcCtD
Ganciclovir—Infection—Methotrexate—urinary bladder cancer	0.000138	0.000313	CcSEcCtD
Ganciclovir—Nausea—Etoposide—urinary bladder cancer	0.000137	0.000313	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—urinary bladder cancer	0.000137	0.000312	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000136	0.000311	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—urinary bladder cancer	0.000136	0.000309	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000136	0.000309	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—urinary bladder cancer	0.000135	0.000307	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—urinary bladder cancer	0.000134	0.000306	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000134	0.000306	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000134	0.000305	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—urinary bladder cancer	0.000134	0.000304	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—urinary bladder cancer	0.000132	0.000302	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—urinary bladder cancer	0.000132	0.000301	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—urinary bladder cancer	0.000132	0.000301	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—urinary bladder cancer	0.000132	0.000301	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—urinary bladder cancer	0.000131	0.0003	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—urinary bladder cancer	0.000131	0.000298	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00013	0.000295	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—urinary bladder cancer	0.00013	0.000295	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—urinary bladder cancer	0.000129	0.000295	CcSEcCtD
Ganciclovir—Infection—Epirubicin—urinary bladder cancer	0.000129	0.000293	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—urinary bladder cancer	0.000128	0.000292	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—urinary bladder cancer	0.000127	0.00029	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000127	0.000289	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—urinary bladder cancer	0.000127	0.000289	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—urinary bladder cancer	0.000126	0.000288	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000126	0.000287	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—urinary bladder cancer	0.000126	0.000287	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000125	0.000285	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—urinary bladder cancer	0.000125	0.000285	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—urinary bladder cancer	0.000125	0.000285	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000125	0.000285	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—urinary bladder cancer	0.000125	0.000285	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—urinary bladder cancer	0.000125	0.000284	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000124	0.000283	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000124	0.000283	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—urinary bladder cancer	0.000124	0.000282	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—urinary bladder cancer	0.000123	0.000281	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000123	0.000281	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—urinary bladder cancer	0.000123	0.00028	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—urinary bladder cancer	0.000122	0.000279	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000122	0.000278	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—urinary bladder cancer	0.000121	0.000276	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—urinary bladder cancer	0.000121	0.000275	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—urinary bladder cancer	0.00012	0.000274	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00012	0.000273	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—urinary bladder cancer	0.00012	0.000273	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00012	0.000272	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—urinary bladder cancer	0.000119	0.000272	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—urinary bladder cancer	0.000119	0.000271	CcSEcCtD
Ganciclovir—Pain—Methotrexate—urinary bladder cancer	0.000118	0.00027	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000118	0.000269	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000117	0.000267	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—urinary bladder cancer	0.000117	0.000267	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—urinary bladder cancer	0.000117	0.000267	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000116	0.000265	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000116	0.000265	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000116	0.000264	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000115	0.000263	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—urinary bladder cancer	0.000115	0.000262	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—urinary bladder cancer	0.000114	0.00026	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000114	0.00026	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000114	0.00026	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000113	0.000258	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000113	0.000257	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—urinary bladder cancer	0.000112	0.000255	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000112	0.000255	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—urinary bladder cancer	0.000112	0.000255	CcSEcCtD
Ganciclovir—Pain—Epirubicin—urinary bladder cancer	0.000111	0.000252	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—urinary bladder cancer	0.000111	0.000252	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—urinary bladder cancer	0.00011	0.000251	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000109	0.000249	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000109	0.000249	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000109	0.000249	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—urinary bladder cancer	0.000108	0.000247	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000108	0.000245	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000107	0.000244	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000107	0.000243	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—urinary bladder cancer	0.000107	0.000243	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000106	0.000241	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000106	0.00024	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000104	0.000237	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000103	0.000236	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—urinary bladder cancer	0.000103	0.000236	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—urinary bladder cancer	0.000103	0.000235	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—urinary bladder cancer	0.000102	0.000234	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—urinary bladder cancer	0.000102	0.000234	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000102	0.000233	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000102	0.000233	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000102	0.000232	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—urinary bladder cancer	9.93e-05	0.000226	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.88e-05	0.000225	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.8e-05	0.000223	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—urinary bladder cancer	9.79e-05	0.000223	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—urinary bladder cancer	9.54e-05	0.000218	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—urinary bladder cancer	9.52e-05	0.000217	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—urinary bladder cancer	9.48e-05	0.000216	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—urinary bladder cancer	9.48e-05	0.000216	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—urinary bladder cancer	9.47e-05	0.000216	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—urinary bladder cancer	9.29e-05	0.000212	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—urinary bladder cancer	9.17e-05	0.000209	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—urinary bladder cancer	9.15e-05	0.000209	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—urinary bladder cancer	8.86e-05	0.000202	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.83e-05	0.000201	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—urinary bladder cancer	8.8e-05	0.000201	CcSEcCtD
Ganciclovir—Rash—Methotrexate—urinary bladder cancer	8.73e-05	0.000199	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—urinary bladder cancer	8.72e-05	0.000199	CcSEcCtD
Ganciclovir—Headache—Methotrexate—urinary bladder cancer	8.67e-05	0.000198	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—urinary bladder cancer	8.6e-05	0.000196	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—urinary bladder cancer	8.57e-05	0.000195	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—urinary bladder cancer	8.48e-05	0.000193	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—urinary bladder cancer	8.24e-05	0.000188	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—urinary bladder cancer	8.22e-05	0.000187	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—urinary bladder cancer	8.2e-05	0.000187	CcSEcCtD
Ganciclovir—Rash—Epirubicin—urinary bladder cancer	8.17e-05	0.000186	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—urinary bladder cancer	8.16e-05	0.000186	CcSEcCtD
Ganciclovir—Headache—Epirubicin—urinary bladder cancer	8.12e-05	0.000185	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—urinary bladder cancer	7.93e-05	0.000181	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—urinary bladder cancer	7.69e-05	0.000175	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—urinary bladder cancer	7.62e-05	0.000174	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—urinary bladder cancer	7.56e-05	0.000172	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—urinary bladder cancer	7.55e-05	0.000172	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—urinary bladder cancer	7.51e-05	0.000171	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—urinary bladder cancer	7.12e-05	0.000162	CcSEcCtD
